Optimizing a Deep Residual Neural Network with Genetic Algorithm for Acute Lymphoblastic Leukemia Classification

BSNEU-net: Block Feature Map Distortion and Switchable Normalization-Based Enhanced Union-net for Acute Leukemia Detection on Heterogeneous Dataset

Acute leukemia is characterized by the swift proliferation of immature white blood cells (WBC) in the blood and bone marrow. It is categorized into acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), depending on whether the cell-line origin is lymphoid or myeloid, respectively. Deep learning (DL) and artificial intelligence (AI) are revolutionizing medical sciences by assisting clinicians with rapid illness identification, reducing workload, and enhancing diagnostic accuracy. This paper proposes a DL-based novel BSNEU-net framework to detect acute leukemia. It comprises 4 Union Blocks (UB) and incorporates block feature map distortion (BFMD) with switchable normalization (SN) in each UB. The UB employs union convolution to extract more discriminant features. The BFMD is adapted to acquire more generalized patterns to minimize overfitting, whereas SN layers are appended to improve the model's convergence and generalization capabilities. The uniform utilization of batch normalization across convolution layers is sensitive to the mini-batch dimension changes, which is effectively remedied by incorporating an SN layer. Here, a new dataset comprising 2400 blood smear images of ALL, AML, and healthy cases is proposed, as DL methodologies necessitate a sizeable and well-annotated dataset to combat overfitting issues. Further, a heterogeneous dataset comprising 2700 smear images is created by combining four publicly accessible benchmark datasets of ALL, AML, and healthy cases. The BSNEU-net model achieved excellent performance with 99.37% accuracy on the novel dataset and 99.44% accuracy on the heterogeneous dataset. The comparative analysis signifies the superiority of the proposed methodology with comparing schemes.

Application of image recognition technology in pathological diagnosis of blood smears

Traditional manual blood smear diagnosis methods are time-consuming and prone to errors, often relying heavily on the experience of clinical laboratory analysts for accuracy. As breakthroughs in key technologies such as neural networks and deep learning continue to drive digital transformation in the medical field, image recognition technology is increasingly being leveraged to enhance existing medical processes. In recent years, advancements in computer technology have led to improved efficiency in the identification of blood cells in blood smears through the use of image recognition technology. This paper provides a comprehensive summary of the methods and steps involved in utilizing image recognition algorithms for diagnosing diseases in blood smears, with a focus on malaria and leukemia. Furthermore, it offers a forward-looking research direction for the development of a comprehensive blood cell pathological detection system.

Modified osprey algorithm for optimizing capsule neural network in leukemia image recognition

The diagnosis of leukemia is a serious matter that requires immediate and accurate attention. This research presents a revolutionary method for diagnosing leukemia using a Capsule Neural Network (CapsNet) with an optimized design. CapsNet is a cutting-edge neural network that effectively captures complex features and spatial relationships within images. To improve the CapsNet's performance, a Modified Version of Osprey Optimization Algorithm (MOA) has been utilized. Thesuggested approach has been tested on the ALL-IDB database, a widely recognized dataset for leukemia image classification. Comparative analysis with various machine learning techniques, including Combined combine MobilenetV2 and ResNet18 (MBV2/Res) network, Depth-wise convolution model, a hybrid model that combines a genetic algorithm with ResNet-50V2 (ResNet/GA), and SVM/JAYA demonstrated the superiority of our method in different terms. As a result, the proposed method is a robust and powerful tool for diagnosing leukemia from medical images.

Hybrid Feature-Learning-Based PSO-PCA Feature Engineering Approach for Blood Cancer Classification

Acute lymphoblastic leukemia (ALL) is a lethal blood cancer that is characterized by an abnormal increased number of immature lymphocytes in the blood or bone marrow. For effective treatment of ALL, early assessment of the disease is essential. Manual examination of stained blood smear images is current practice for initially screening ALL. This practice is time-consuming and error-prone. In order to effectively diagnose ALL, numerous deep-learning-based computer vision systems have been developed for detecting ALL in blood peripheral images (BPIs). Such systems extract a huge number of image features and use them to perform the classification task. The extracted features may contain irrelevant or redundant features that could reduce classification accuracy and increase the running time of the classifier. Feature selection is considered an effective tool to mitigate the curse of the dimensionality problem and alleviate its corresponding shortcomings. One of the most effective dimensionality-reduction tools is principal component analysis (PCA), which maps input features into an orthogonal space and extracts the features that convey the highest variability from the data. Other feature selection approaches utilize evolutionary computation (EC) to search the feature space and localize optimal features. To profit from both feature selection approaches in improving the classification performance of ALL, in this study, a new hybrid deep-learning-based feature engineering approach is proposed. The introduced approach integrates the powerful capability of PCA and particle swarm optimization (PSO) approaches in selecting informative features from BPI mages with the power of pre-trained CNNs of feature extraction. Image features are first extracted through the feature-transfer capability of the GoogleNet convolutional neural network (CNN). PCA is utilized to generate a feature set of the principal components that covers 95% of the variability in the data. In parallel, bio-inspired particle swarm optimization is used to search for the optimal image features. The PCA and PSO-derived feature sets are then integrated to develop a hybrid set of features that are then used to train a Bayesian-based optimized support vector machine (SVM) and subspace discriminant ensemble-learning (SDEL) classifiers. The obtained results show improved classification performance for the ML classifiers trained by the proposed hybrid feature set over the original PCA, PSO, and all extracted feature sets for ALL multi-class classification. The Bayesian-optimized SVM trained with the proposed hybrid PCA-PSO feature set achieves the highest classification accuracy of 97.4%. The classification performance of the proposed feature engineering approach competes with the state of the art.

An Artificial Intelligence-as-a-Service Architecture for deep learning model embodiment on low-cost devices: A case study of COVID-19 diagnosis

Coronavirus Disease-2019 (COVID-19) causes Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) and has opened several challenges for research concerning diagnosis and treatment. Chest X-rays and computed tomography (CT) scans are effective and fast alternatives to detect and assess the damage that COVID causes to the lungs at different stages of the disease. Although the CT scan is an accurate exam, the chest X-ray is still helpful due to the cheaper, faster, lower radiation exposure, and is available in low-incoming countries. Computer-aided diagnostic systems based on Artificial Intelligence (AI) and computer vision are an alternative to extract features from X-ray images, providing an accurate COVID-19 diagnosis. However, specialized and expensive computational resources come across as challenging. Also, it needs to be better understood how low-cost devices and smartphones can hold AI models to predict diseases timely. Even using deep learning to support image-based medical diagnosis, challenges still need to be addressed once the known techniques use centralized intelligence on high-performance servers, making it difficult to embed these models in low-cost devices. This paper sheds light on these questions by proposing the Artificial Intelligence as a Service Architecture (AIaaS), a hybrid AI support operation, both centralized and distributed, with the purpose of enabling the embedding of already-trained models on low-cost devices or smartphones. We demonstrated the suitability of our architecture through a case study of COVID-19 diagnosis using a low-cost device. Among the main findings of this paper, we point out the performance evaluation of low-cost devices to handle COVID-19 predicting tasks timely and accurately and the quantitative performance evaluation of CNN models embodiment on low-cost devices.

Artificial intelligence applications in pediatric oncology diagnosis

Artificial intelligence (AI) algorithms have been applied in abundant medical tasks with high accuracy and efficiency. Physicians can improve their diagnostic efficiency with the assistance of AI techniques for improving the subsequent personalized treatment and surveillance. AI algorithms fundamentally capture data, identify underlying patterns, achieve preset endpoints, and provide decisions and predictions about real-world events with working principles of machine learning and deep learning. AI algorithms with sufficient graphic processing unit power have been demonstrated to provide timely diagnostic references based on preliminary training of large amounts of clinical and imaging data. The sample size issue is an inevitable challenge for pediatric oncology considering its low morbidity and individual heterogeneity. However, this problem may be solved in the near future considering the exponential advancements of AI algorithms technically to decrease the dependence of AI operation on the amount of data sets and the efficiency of computing power. For instance, it could be a feasible solution by shifting convolutional neural networks (CNNs) from adults and sharing CNN algorithms across multiple institutions besides original data. The present review provides important insights into emerging AI applications for the diagnosis of pediatric oncology by systematically overviewing of up-to-date literature.

Application of Meta-Heuristic Algorithms for Training Neural Networks and Deep Learning Architectures: A Comprehensive Review

The learning process and hyper-parameter optimization of artificial neural networks (ANNs) and deep learning (DL) architectures is considered one of the most challenging machine learning problems. Several past studies have used gradient-based back propagation methods to train DL architectures. However, gradient-based methods have major drawbacks such as stucking at local minimums in multi-objective cost functions, expensive execution time due to calculating gradient information with thousands of iterations and needing the cost functions to be continuous. Since training the ANNs and DLs is an NP-hard optimization problem, their structure and parameters optimization using the meta-heuristic (MH) algorithms has been considerably raised. MH algorithms can accurately formulate the optimal estimation of DL components (such as hyper-parameter, weights, number of layers, number of neurons, learning rate, etc.). This paper provides a comprehensive review of the optimization of ANNs and DLs using MH algorithms. In this paper, we have reviewed the latest developments in the use of MH algorithms in the DL and ANN methods, presented their disadvantages and advantages, and pointed out some research directions to fill the gaps between MHs and DL methods. Moreover, it has been explained that the evolutionary hybrid architecture still has limited applicability in the literature. Also, this paper classifies the latest MH algorithms in the literature to demonstrate their effectiveness in DL and ANN training for various applications. Most researchers tend to extend novel hybrid algorithms by combining MHs to optimize the hyper-parameters of DLs and ANNs. The development of hybrid MHs helps improving algorithms performance and capable of solving complex optimization problems. In general, the optimal performance of the MHs should be able to achieve a suitable trade-off between exploration and exploitation features. Hence, this paper tries to summarize various MH algorithms in terms of the convergence trend, exploration, exploitation, and the ability to avoid local minima. The integration of MH with DLs is expected to accelerate the training process in the coming few years. However, relevant publications in this way are still rare.

Entropy Measurements for Leukocytes' Surrounding Informativeness Evaluation for Acute Lymphoblastic Leukemia Classification

The study of leukemia classification using deep learning techniques has been conducted by multiple research teams worldwide. Although deep convolutional neural networks achieved high quality of sick vs. healthy patient discrimination, their inherent lack of human interpretability of the decision-making process hinders the adoption of deep learning techniques in medicine. Research involving deep learning proved that distinguishing between healthy and sick patients using microscopic images of lymphocytes is possible. However, it could not provide information on the intermediate steps in the diagnosis process. As a result, despite numerous examinations, it is still unclear whether the lymphocyte is the only object in the microscopic picture containing leukemia-related information or if the leukocyte's surroundings also contain the desired information. In this work, entropy measures and machine learning models were applied to study the informativeness of both whole images and lymphocytes' surroundings alone for Leukemia classification. This work aims to provide human-interpretable features marking the probability of sickness occurrence. The research stated that the hue distribution of images with lymphocytes obfuscated alone is informative enough to facilitate 93.0% accuracy in healthy vs. sick classification. The research was conducted on the ALL-IDB2 dataset.